BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

George Yohrling of the HDSA Explains AMT-130 Gene Therapy

  1. scout41
    536 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    29/11/17
    07:49
    Post #: 29199275
    George Yohrling of the HDSA Explains AMT-130 Gene Therapy
    BLT Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Want to talk crypto? Click here to join the discussion!
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
UNT UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.